Skip to main content
. 2008 Nov 10;113(13):2888–2894. doi: 10.1182/blood-2008-07-168401

Figure 3.

Figure 3

Cumulative incidence of secondary therapy among patients with acute GVHD initially given either low-dose glucocorticoids (prednisone-equivalent dose of 1 mg/kg per day) or standard-dose glucocorticoids (prednisone-equivalent dose of 2 mg/kg per day). (Left panel) Nonglucocorticoid secondary therapy. (Right panel) Increased glucocorticoid dose or nonglucocorticoid secondary therapy.